Of special interest is a spectrum of EGFR, ABL, MET, FLT3 and KIT cancer mutations that correspond to the same structurally conserved position in the activation loop, which appeared to be mutated in at least 8 different kinases (Figure 6A, Table S1). The gene discussed is MET; the disease is cancer.